NEW YORK (GenomeWeb) – The US Food and Drug Administration today issued a draft guidance document that aims to make it easier to get oncology-class labeling on companion diagnostic tests for therapeutic products.

Broadly, the initiative aims to address labeling challenges associated with developing companion diagnostics that can help target the delivery of cancer drugs, FDA Commissioner Scott Gottlieb said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.